Results 161 to 170 of about 4,766 (189)

Cobicistat/elvitegravir/emtricitabine/tenofovir-alafenamide

Reactions Weekly, 2018
  +6 more sources

Cobicistat/elvitegravir/emtricitabine/tenofovir alafenamide

Reactions Weekly, 2021
  +4 more sources

Efficacy and safety of co-formulated elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in HIV-positive patients: real-world data

International Journal of STD and AIDS, 2021
Fehmi Tabak, Esra Zerdali, Alper Gunduz   +2 more
exaly  

Clinically Significant Lower Elvitegravir Exposure During the Third Trimester of Pregnant Patients Living With Human Immunodeficiency Virus: Data From the Pharmacokinetics of ANtiretroviral agents in HIV-infected pregNAnt women (PANNA) Network

Clinical Infectious Diseases, 2020
Vera E Bukkems, Jürgen Rockstroh, John S Lambert   +2 more
exaly  

Cobicistat/elvitegravir/emtricitabine/tenofovir-alafenamide

Reactions Weekly, 2022
openaire   +2 more sources

Changes in neurocognitive assessment scores after initiating dolutegravir- versus elvitegravir-based antiretroviral therapy

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 2021
Jessica L Adams, Laura Pontiggia, John D Baxter   +2 more
exaly  

Impact of elvitegravir on human adipocytes: Alterations in differentiation, gene expression and release of adipokines and cytokines

Antiviral Research, 2016
Père Domingo, JOSÉ M Gallego-Escuredo, Joan Villarroya   +2 more
exaly  

ELVITEGRAVIR /

2014
openaire   +1 more source

Dolutegravir/elvitegravir/raltegravir

Reactions Weekly, 2017
openaire   +1 more source

Elvitegravir

2017
openaire   +1 more source